Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

75 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
Adamek RJ, Behrendt J, Wenzel C. Adamek RJ, et al. Eur J Gastroenterol Hepatol. 2001 Jul;13(7):811-7. doi: 10.1097/00042737-200107000-00009. Eur J Gastroenterol Hepatol. 2001. PMID: 11474311 Clinical Trial.
[Short-term triple therapy with pantoprazole, clarithromycin and metronidazole for the healing of Helicobacter pylori infection].
Adamek RJ, Szymanski C, Pfaffenbach B, Opferkuch W, Ricken D, Wegener M. Adamek RJ, et al. Dtsch Med Wochenschr. 1995 Mar 17;120(11):358-60. doi: 10.1055/s-2008-1055353. Dtsch Med Wochenschr. 1995. PMID: 7889816 Clinical Trial. German.
The lack of influence of CagA positive Helicobacter pylori strains on gastro-oesophageal reflux disease.
Kiltz U, Pfaffenbach B, Schmidt WE, Adamek RJ. Kiltz U, et al. Among authors: adamek rj. Eur J Gastroenterol Hepatol. 2002 Sep;14(9):979-84. doi: 10.1097/00042737-200209000-00008. Eur J Gastroenterol Hepatol. 2002. PMID: 12352217
Pantoprazole suppresses Helicobacter pylori without affecting cure.
Adamek RJ, Szymanski C, Pfaffenbach B. Adamek RJ, et al. Helicobacter. 1999 Dec;4(4):266-71. doi: 10.1046/j.1523-5378.1999.99991.x. Helicobacter. 1999. PMID: 10597397 Clinical Trial.
75 results
Jump to page
Feedback